Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro by Raymonda, M.H., Ciesla, J.H., Monaghan, M., Leach, J., Asantewaa, G., Smorodintsev-Schiller, L.A., Lutz, M.M., Schafer, X.L., Takimoto, T., Dewhurst, S., Munger, J., Harris, I.S.

Get full text

The Micro-Mainframe Link by Lutz, Merritt M

Get full text

PO-1306 Response to induction chemotherapy on PET/CT predicts post-RT progression in patients with NSCLC by Tvilum, M., Knap, M.M., Khalil, A.A., Hoffmann, L., Lutz, C.M., Appelt, A., Schmidt, H.H., Møller, D.S.

Get full text

Nocturia in men and associated comorbidities: a southeast Michigan study by Daniel Fortney, Prasun Sharma, Alexander Geisenhoff, Bernadette M.M. Zwaans, Michael D Lutz

Get full text

OC-0439 Geometric and dosimetric stability of high FDG-uptake volumes during dose escalated RT of NSCLC by Møller, D.S., Hoffmann, L., Haraldsen, A., Knap, M.M., Khalil, A.A., Lutz, C.M.

Get full text

PO-1305 Pattern of failure of LD-SCLC treated with chemoradiotherapy: dependence on disease stage by Schmidt, H.H., Moeller, D.S., Hoffmann, L., Lutz, C.M., Kandi, M., Mortensen, L.S., Tvilum, M., Khalil, A., Knap, M.M.

Get full text

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of... by Godoy, Patricio, Hewitt, Nicola J., Albrecht, Ute, Andersen, Melvin E., Ansari, Nariman, Bhattacharya, Sudin, Bode, Johannes Georg, Bolleyn, Jennifer, Borner, Christoph, Böttger, Jan, Braeuning, Albert, Budinsky, Robert A., Burkhardt, Britta, Cameron, Neil R., Camussi, Giovanni, Cho, Chong-Su, Choi, Yun-Jaie, Craig Rowlands, J., Dahmen, Uta, Damm, Georg, Dirsch, Olaf, Donato, María Teresa, Dong, Jian, Dooley, Steven, Drasdo, Dirk, Eakins, Rowena, Ferreira, Karine Sá, Fonsato, Valentina, Fraczek, Joanna, Gebhardt, Rolf, Gibson, Andrew, Glanemann, Matthias, Goldring, Chris E. P., Gómez-Lechón, María José, Groothuis, Geny M. M., Gustavsson, Lena, Guyot, Christelle, Hallifax, David, Hammad, Seddik, Hayward, Adam, Häussinger, Dieter, Hellerbrand, Claus, Hewitt, Philip, Hoehme, Stefan, Holzhütter, Hermann-Georg, Houston, J. Brian, Hrach, Jens, Ito, Kiyomi, Jaeschke, Hartmut, Keitel, Verena, Kelm, Jens M., Kevin Park, B., Kordes, Claus, Kullak-Ublick, Gerd A., LeCluyse, Edward L., Lu, Peng, Luebke-Wheeler, Jennifer, Lutz, Anna, Maltman, Daniel J., Matz-Soja, Madlen, McMullen, Patrick, Merfort, Irmgard, Messner, Simon, Meyer, Christoph, Mwinyi, Jessica, Naisbitt, Dean J., Nussler, Andreas K., Olinga, Peter, Pampaloni, Francesco, Pi, Jingbo, Pluta, Linda, Przyborski, Stefan A., Ramachandran, Anup, Rogiers, Vera, Rowe, Cliff, Schelcher, Celine, Schmich, Kathrin, Schwarz, Michael, Singh, Bijay, Stelzer, Ernst H. K., Stieger, Bruno, Stöber, Regina, Sugiyama, Yuichi, Tetta, Ciro, Thasler, Wolfgang E., Vanhaecke, Tamara, Vinken, Mathieu, Weiss, Thomas S., Widera, Agata, Woods, Courtney G., Xu, Jinghai James, Yarborough, Kathy M., Hengstler, Jan G.

Get full text

Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations by Koczorowska, M.M., Tholen, S., Bucher, F., Lutz, L., Kizhakkedathu, J.N., De Wever, O., Wellner, U.F., Biniossek, M.L., Stahl, A., Lassmann, S., Schilling, O.

Request full text

PD-0876 First-failure prediction model for locally advanced non-small cell lung cancer - External validation by Lutz, C.M., Knap, M.M., Møller, D.S., Hoffmann, L., Khalil, A.A., Håkansson, K.E., Persson, G., Bentzen, S., Nygård, L., Vogelius, I.

Get full text

PD-0846 Tumor match and adaptive radiotherapy reduce risk of radiation pneumonitis and increase survival by Møller, D.S., Lutz, C.M., Alber, M., Khalil, A.A., Holt, M.I., Schmidt, H.H., Appelt, A.L., Knap, M.M., Hoffmann, L.

Get full text

PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC by Tvilum, M., Knap, M.M., Lutz, C.M., Hoffmann, L., Khalil, A.A., Haraldsen, A., Alber, M., Grau, C., Schmidt, H.H., Kandi, M., Mortensen, L.S., Holt, M.I., Appelt, A., Moeller, D.S.

Get full text

PD-0664 Risk factors of radiation pneumonitis in modern adaptive radiotherapy by Lutz, C.M., Møller, D.S., Appelt, A., Alber, M., Hoffmann, L., Khalil, A.A., Holt, M.I., Kandi, M., Schmidt, H.H., Tvilum, M., Knap, M.M.

Get full text

OC-0450 Model-based selection of NSCLC patients for proton therapy with heterogeneous dose distributions by van Bogerijen, G.H., Fuglsang Jensen, M., Lykkegaard Ehmsen, M., Hoffmann, L., Shamshad, M., Lutz, C.M., Knap, M.M., Mortensen, H.R., Møller, D.S., Nuyttens, J.J.

Get full text

EP05.01-017 Exploring the Benefits of Adaptive Radiotherapy in NSCLC-patients by Tvilum, M., Lutz, C.M., Khalil, A., Alber, M., Holt, M.I., Kandi, M., Schmidt, H.H., Appelt, A., Knap, M.M., Hoffmann, L., Møller, D.S.

Get full text

Reliability of dose volume constraint inference from clinical data by Lutz, C M, Møller, D S, Hoffmann, L, Knap, M M, Alber, M

Get full text

PO-1581: Prospectively scored pulmonary toxicities from a non-small cell lung cancer dose escalation trail by Lutz, C.M., Knap, M.M., Hoffmann, L., Moeller, D.S., Hansen, O., Brink, C., Schytte, T., Nyhus, C., McCulloch, T., Borissova, S., Alber, M., Khalil, A.

Get full text

EP-1614: Uncertainty of dose-volume constraints obtained from radiation pneumonitis dose-response analysis by Lutz, C.M., Møller, D.S., Hoffmann, L., Khalil, A.A., Knap, M.M., Alber, M.

Get full text

Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss by Hope, David C.D., Hinds, Charlotte E., Lopes, Tatiana, Vincent, Matthew L., Shrewsbury, Jed V., Yu, Arthur T.C., Davies, Iona, Scott, Rebecca, Jones, Ben, Murphy, Kevin G., Minnion, James S., Sardini, Alessandro, Carling, David, Lutz, Thomas A., Bloom, Stephen R., Tan, Tricia M.M., Owen, Bryn M.

Get full text

Influences on PET Quantification and Interpretation by Rogasch, Julian M M, Hofheinz, Frank, van Heek, Lutz, Voltin, Conrad-Amadeus, Boellaard, Ronald, Kobe, Carsten

Get full text

OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial by Moeller, D.S, Hoffmann, L, Lutz, C.M, Nielsen, T.B, Brink, C, Appelt, A.L, Lund, M.D, Nielsen, M.S, Ottosson, W, Khalil, A.A, Knap, M.M, Hansen, O, Schytte, T

Get full text